Vicapsys Life Sciences, Inc. (VICP)

Vicapsys Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2009
Revenue	0	0	0	0	7.78
Revenue Growth (YoY)	-	-	-	-	14.45%
Cost of Revenue	0.03	0.03	0.03	0.03	7.24
Gross Profit	-0.03	-0.03	-0.03	-0.03	0.54
Selling, General & Admin	0.63	0.32	0.66	0.93	1.85
Research & Development	0.01	0.02	0.1	0.1	0
Other Operating Expenses	0.46	0.09	286.33	0	0.05
Operating Expenses	0.64	0.34	0.77	1.03	1.9
Operating Income	-0.98	-0.34	-0.77	-1.03	-1.35
Interest Income	0	0	0	0	0
Interest Expense	-0.68	0	0	0	0.32
Other Expense / Income	0.68	-0.1	0	-	-
Pretax Income	-0.98	-0.24	-0.77	-1.03	-1.67
Income Tax	0.68	-0.1	-0	0.38	-0
Net Income	-1.67	-0.14	-0.77	-1.41	-1.67
Shares Outstanding (Basic)	31	18	17	11	0
Shares Outstanding (Diluted)	31	18	17	11	0
Shares Change	73.18%	0.99%	53.32%	3188.17%	1.94%
EPS (Basic)	-0.05	-0.01	-0.04	-0.12	-4.82
EPS (Diluted)	-0.05	-0.01	-0.04	-0.12	-4.82
Free Cash Flow	-0.24	-0.44	-0.26	-0.97	-1.47
Free Cash Flow Per Share	-0.01	-0.03	-0.02	-0.09	-4.24
Gross Margin	-	-	-	-	6.99%
Operating Margin	-	-	-	-	-17.39%
Profit Margin	-	-	-	-	-21.45%
Free Cash Flow Margin	-	-	-	-	-18.88%
EBITDA	-0.27	-0.41	-0.73	-1	-1.23
EBITDA Margin	-	-	-	-	-15.80%
Depreciation & Amortization	0.03	0.03	0.03	0.03	0.12
EBIT	-0.3	-0.44	-0.77	-1.03	-1.35
EBIT Margin	-	-	-	-	-17.36%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.